title: Ticlopidine induced cholestatic jaundice.
abstract: Ticlopidine hydrochloride (Ticlid) has been increasingly used as an antiplatelet agent. Some studies showed that it has higher efficacy in reducing stroke recurrence when compared to conventional aspirin. Side effects like gastrointestinal disturbances and blood dyscrasias are common but ticlopidine-induced cholestatic jaundice has been reported only rarely. We present a case report on a patient who has ticlopidine-induced cholestatic jaundice.
authors.affiliation: Department of Geriatric Medicine, Tan Tock Seng Hospital, Singapore.
authors.forename: H B
authors.initials: HB
authors.lastname: Yim
authors.forename: P K
authors.initials: PK
authors.lastname: Lieu
authors.forename: P W
authors.initials: PW
authors.lastname: Choo
mesh_terms: D000368:Aged; D002561:Cerebrovascular Disorders / Q000150:complications / Q000188:drug therapy; D002779:Cholestasis / Q000139:chemically induced* / Q000175:diagnosis; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D013988:Ticlopidine / Q000009:adverse effects*
chemical_list: D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine